On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- Top Insights from The Scope Forward Show 2025
- Augmented Reality to Improve Ergonomics; Positive Stool Tests and Polyp Location (GI & Endoscopy News)
- Capsule Endoscopy (GI & Endoscopy News)
- Underused Method of Colorectal Endoscopic Submucosal Dissection Could Improve Outcomes (Medscape)
- OpenAI launches ChatGPT Health, partners with b.well (MobiHealthNews)
- Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions (Freenome)
- Ro Launches Wegovy® Pill Through Integration with Novo Nordisk (Ro)
- The impact of the GI physician shortage (Becker’s GI & Endoscopy)
